INTRODUCTION
It has been known for some time that background gradients can distort diffusion measurements (1) . More recently, it was shown that when the background gradient is not constant over the volume, but distributed in a gaussian manner, the apparent diffusion coefficient (ADC) is reduced (2) . Demonstrations of this phenomenon were made with computer simulations, microsphere phantoms, and in ex-vivo rat livers containing a superparamagnetic contrast agent (AMI-125) (2) .
This abstract presents in-vivo measurements of ADC reduction due to a distribution of background gradients resulting from induced intravascular susceptibility variations. The ADC reduction is found to correlate approximately linearly with both intravascular susceptibility (Ax) and R}. Interpolation indicates that for the pulse-sequence parameters employed in these measurements, an ADC change of up to :5% can result from blood-oxygenation changing from fully oxygenated to fully deoxygenated.
METHODS
Imaging was performed at 2.0 Tesla on a smallbore, GE Omega CSI system, using a 50 mm diameter home-built birdcage coil, and Acustar imaging gradients. Rat brain images were generated using a 40 mm FOV, 64 samples x 32 phase-encode steps, 2 NEX, TR = 2 s. ADC and R} were measured using a series of four images: two gradient-echo images-TE = 7 ms and 30 ms-and two spin-echo images-TE = 42 ms, A = 23 ms, 6 = 8 ms, with read-direction, half-sine diffusion-sensitising gradients of 0.1 G/cm and 18 G/cm. Intravascular susceptibility was varied using 0.3 mL injections of superparamagnetic contrast agent AMI-227, with an iron concentration of 2 mg/mL. Two sets of images were generated before the first and following each injection.
Corresponding to each set of images, = 0.3 mL of blood was sampled and later used to measure the susceptibility change resulting from the contrast agent. Experiments were repeated on five different female Sprague-Dawley rats, weighing approximately 200g each.
RESULTS AND DISCUSSION
R}, ADC, and AX were all found to change approximately linearly with increasing AMI-227 injections. For all three measures, mean data were fit to a linear dependence on iron dose. The ADC data was also normalised to I for the baseline case of no increase. Fig. 1 shows the mean ADC data as a function of AMI-227 dose-errorbars indicate standard deviations over the five rats. Also shown in Fig. 1 is the range over which blood oxygenation levels could alter ADC. Vertical grey bar corresponds to the range of susceptibility from fully oxygenated to fully deoxygenated blood (3), and the horizontal grey bar shows the resulting ADC reductions over that range of intravascular susceptibility. Note that the observed ADC changes are dependent upon various pulse-sequence parameters and, therefore, may vary significantly from one ADC measurement protocol to another.
CONCLUSION
Intravascular susceptibility changes induce microscopic background gradients in rat brain tissue, which, in-turn, result in a decrease in the ADC. For a PGSE sequence, with the aforementioned timings, this ADC reduction is approximately 7% per mg of iron, which corresponds to an expected ADC reduction of up to 5% due to maximum blood-oxygenation level changes.
